Medicare Enrolled
Dr. Peter Rubin, M.D.
Optician · New York, NY
Practice pattern: Clinical Cardiology
— Primarily office-based clinical cardiology
Low-engagement
Very High
DATA COVERAGE
Data in 4 of 4 federal sources
Measures public federal data availability — not provider quality
Informational, not a quality rating.
This page presents federal public records about Dr. Rubin from CMS (NPPES, Open Payments, Medicare Provider Utilization, PECOS). It is not medical advice, an endorsement, or a judgment of clinical quality. Always consult the provider directly and a licensed clinician for medical decisions. Read methodology →
Are you Dr. Rubin?
Request a correction or review of any data shown here. Provider portal →
What this data tells you about Dr. Rubin
Dr. Peter Rubin is an optician specialist in New York, NY, with 20 years of NPI registration. Based on federal Medicare data, Dr. Rubin performed 2,578 Medicare services across 1,513 unique beneficiaries.
Between the years covered by Open Payments, Dr. Rubin received a total of $14,577 from 45 pharmaceutical and/or device companies across 745 individual payments. These payments are legal, publicly disclosed under the federal Sunshine Act, and common in optician. Most payments are for meals and travel — low-value interactions common across virtually all practicing physicians. Patients may wish to discuss these relationships with their provider.
The Data Coverage level for Dr. Rubin is Very High — reflecting how much public federal data is available about this provider. Patients are encouraged to use this data as one of several factors when choosing a healthcare provider.
✓ 20 years in practice
▲ Top 30% volume in NY
$14,577 industry payments
Medicare Practice Summary
Medicare Utilization ↗2,578
Medicare services
Top 30% in NY for optician
1,513
Unique beneficiaries
$76
Avg. Medicare payment
Medicare patients only (65+ / disabled) · How to read this →
~129 Medicare services per year of practice
Top procedures by volume
Ranked by number of services performed for Medicare patients. Avg. submitted charge is what the provider billed; avg. Medicare payment is what CMS paid.
| Procedure | Volume | Avg. paid | Avg. submitted |
|---|---|---|---|
| Blood draw (venipuncture) Insertion of a needle into a vein to collect a blood sample. |
913 | $8 | $40 |
| Office visit, established patient (30-39 min) A follow-up office visit for an existing patient lasting between 30 and 39 minutes. The visit involves medical evaluation and management of the patient's condition. |
516 | $110 | $235 |
| Office visit, established patient (20-29 min) An office visit for an existing patient lasting between 20 and 29 minutes. The visit involves medical evaluation and management of the patient's condition. |
348 | $75 | $180 |
| Hospital follow-up visit, moderate complexity Follow-up hospital visit for an existing patient involving moderate medical decision making. The visit requires at least 35 minutes of time spent on the date of service. |
236 | $71 | $240 |
| Electrocardiogram (EKG), 12-lead A standard heart rhythm test using at least 12 leads to record electrical activity. A healthcare provider interprets the results and provides a written report. |
119 | $12 | $125 |
| Upper GI endoscopy with biopsy A procedure to collect tissue samples from the esophagus, stomach, or upper small intestine using a flexible tube with a camera. The samples are examined to check for abnormalities. |
79 | $337 | $1,100 |
| New patient office visit (45-59 min) An initial office visit for a new patient lasting between 45 and 59 minutes. This code covers the total time spent by the physician or qualified healthcare professional on the date of the encounter. |
78 | $137 | $490 |
| Flu vaccine administration This procedure involves the administration of the influenza virus vaccine. It covers the process of delivering the vaccine to the patient. |
48 | $35 | $40 |
| Colonoscopy A diagnostic exam of the large bowel using a flexible endoscope to visualize the interior of the colon. |
46 | $292 | $2,000 |
| Quadrivalent influenza vaccine, cell culture-derived A flu shot that protects against four strains of the influenza virus. It is produced using cell culture technology rather than traditional egg-based methods. |
44 | $32 | $50 |
| Colon polyp removal with endoscopic snare This procedure removes polyps or growths from the large bowel using a flexible tube with a camera and a wire loop tool. The snare is used to cut off the growths during the examination. |
42 | $411 | $2,500 |
| Colonoscopy with biopsy A procedure to collect tissue samples from the large intestine using a flexible tube with a camera. The samples are examined to check for abnormalities or disease. |
32 | $380 | $2,200 |
| Initial hospital admission, moderate complexity Initial hospital inpatient or observation care for a new patient involving moderate-level medical decision making, with at least 55 minutes total time on the date of the encounter. |
23 | $116 | $275 |
| Vitamin B-12 injection An injection of vitamin B-12 (cyanocobalamin) with a dose of up to 1000 mcg. |
23 | $1 | $16 |
| Office visit, established patient (10-19 min) An office visit for an existing patient lasting 10 to 19 minutes. The visit involves medical evaluation and management of the patient's condition. |
18 | $49 | $130 |
| Hospital discharge day management, 30 minutes or less This service covers the final day of hospital care when the patient is being discharged. It includes coordination of care and instructions for the patient within a time frame of 30 minutes or less. |
13 | $72 | $325 |
How to read this data: This reflects Medicare patients only (typically 65+). Payment amounts are what Medicare paid the provider, not your out-of-pocket cost. A higher procedure volume generally indicates more experience with that procedure.
Industry Payment Transparency
Open Payments through 2024 ↗$14,577
Total received (2018-2024)
Avg $2,082/year across 7 years
Top 11% in NY for optician
A higher payment rank reflects disclosed industry relationships (consulting, research, speaking) common among subspecialists — not wrongdoing.
45
Companies
745
Individual payments
All payments are legal and publicly reported · Not evidence of wrongdoing · How to interpret →
Payment profile
Industry payments classified by relationship type. Not all payments are equal — research and consulting reflect different relationships than speaking programs or meals.
Meals & Travel
Food, beverages, travel, and lodging — typically low-value
$14,452 (99.1%)
Speaking / Promotional
Speaker programs, honoraria, and industry-sponsored educational events
$69 (0.5%)
Consulting
Expert advisory fees, typically reflecting recognized clinical expertise
$56 (0.4%)
Payment trend by year
Annual totals from pharmaceutical and medical device companies.
2024
$3,119
2023
$2,420
2022
$1,849
2021
$1,615
2020
$792
2019
$2,770
2018
$2,011
Payments by company (2024)
Consulting
Speaking
Meals & Travel
Research
ABBVIE INC.
$877
Takeda Pharmaceuticals U.S.A., Inc.
$598
QOL Medical, LLC
$451
Celgene Corporation
$423
Salix Pharmaceuticals, a division of Bausch Health US, LLC
$198
Janssen Biotech, Inc.
$195
PFIZER INC.
$151
Lilly USA, LLC
$47
Boehringer Ingelheim Pharmaceuticals, Inc.
$46
Exact Sciences Corporation
$29
Sandoz Inc.
$23
Regeneron Healthcare Solutions, Inc.
$21
Actelion Pharmaceuticals US, Inc.
$21
Smith+Nephew, Inc.
$19
Merck Sharp & Dohme LLC
$19
Top 3 companies account for 61.8% of 2024 payments
All-time payments by company (2018-2024) ›
Salix Pharmaceuticals, a division of Bausch Health US, LLC
$2,239
Takeda Pharmaceuticals U.S.A., Inc.
$1,767
Celgene Corporation
$1,343
QOL Medical, LLC
$1,259
ABBVIE INC.
$1,241
AbbVie Inc.
$961
UCB, Inc.
$876
Janssen Biotech, Inc.
$809
PFIZER INC.
$584
AbbVie, Inc.
$570
Shire North American Group Inc
$550
Ferring Pharmaceuticals Inc.
$330
Amgen Inc.
$192
Boehringer Ingelheim Pharmaceuticals, Inc.
$169
Merck Sharp & Dohme Corporation
$146
Synergy Pharmaceuticals Inc
$122
Ironwood Pharmaceuticals, Inc
$120
Concordia Pharmaceuticals Inc.
$116
GlaxoSmithKline, LLC.
$112
Prometheus Laboratories Inc.
$109
Allergan Inc.
$100
Sandoz Inc.
$93
Braintree Laboratories, Inc.
$84
Exact Sciences Corporation
$81
Intercept Pharmaceuticals, Inc.
$72
IRONWOOD PHARMACEUTICALS, INC
$67
Janssen Pharmaceuticals, Inc
$48
Actelion Pharmaceuticals US, Inc.
$47
Lilly USA, LLC
$47
SANOFI-AVENTIS U.S. LLC
$40
Daiichi Sankyo Inc.
$28
Boston Scientific Corporation
$24
Sobi, Inc
$24
Ortho Dermatologics, a division of Bausch Health US, LLC
$23
Regeneron Healthcare Solutions, Inc.
$21
Smith+Nephew, Inc.
$19
Merck Sharp & Dohme LLC
$19
Allergan, Inc.
$18
Endo Pharmaceuticals Inc.
$18
Kowa Pharmaceuticals America, Inc.
$16
AstraZeneca Pharmaceuticals LP
$16
Oxford Immunotec USA Inc
$16
E.R. Squibb & Sons, L.L.C.
$16
Gilead Sciences, Inc.
$14
Romark Laboratories, LC
$10
Top 3 companies account for 36.7% of all-time payments
Associated products mentioned in payments ›
APRISO · Alinia Tablets 500mg 30 count bottle · Amitiza · BOOSTRIX · CIMZIA · CLENPIQ · CREON · CYLTEZO · Cimzia · Cologuard Collection Kit · Creon · DIFICID · DONNATAL · DUPIXENT · Dexilant · Donnatal · ENTYVIO · Entyvio · FARXIGA · GAMIFANT · GARDASIL · GATTEX · GRAFIX PL · General - Polypectomy · HUMIRA · HYRIMOZ · Humira · INFLECTRA · INJECTAFER · JARDIANCE · LINZESS · Linzess · Livalo · MOTEGRITY · MOTOFEN · MOUNJARO · NASCOBAL · OCALIVA · OPSUMIT · PLENVU · PNEUMOVAX 23 · PRALUENT · PREPOPIK · REBLOZYL · RINVOQ · Repatha · SHINGRIX · SKYRIZI · STELARA · SUCRAID · SUPREP BOWEL PREP · Sucraid · T-SPOT.TB8 · TREMFYA · TRULANCE · Trulance · UCERIS · UCERIS TABLETS · VIBERZI · XARELTO · XELJANZ · XERESE · XIFAXAN · XIFAXANIBSD · ZENPEP · ZEPOSIA
Should you be concerned? Payments from pharmaceutical and device companies are legal and common — 57% of U.S. physicians receive at least one. They often reflect legitimate consulting, research, or education. What matters is whether a recommended drug or device appears in your doctor's payment records. If so, consider asking your doctor about it. How to interpret this data →
Most payments (99%) are for meals and travel — low-value interactions that are common across virtually all practicing physicians.
Geographic Context
Opticians within 10 mi
16,073
Per 100K population
987.4
County median income
$104,553
Nearest hospital
LENOX HILL HOSPITAL
0.3 mi
0.3 mi
Data Sources
| Provider Registry | ✓ NPPES | Weekly updates |
| Medicare Enrollment | ✓ PECOS | Monthly updates |
| Practice Data | ✓ Medicare Util. | Annual (CY lag) |
| Industry Payments | ✓ Open Payments | CY 2024 |
| Disciplinary History | — Not public | N/A |
This provider has data in 4 of 4 available federal datasets, with a Data Coverage level of Very High. This reflects how much public data is available about a provider. How we calculate this →
Summary
Dr. Rubin is a clinical cardiology specialist, with above-average Medicare volume (top 30% in NY), with low-engagement industry engagement in the top 11% of NY peers, with 20 years of NPI registration.
This summary is auto-generated from federal data, describing data availability and patterns. Read our methodology →
Frequently Asked Questions
Is Dr. Rubin experienced with blood draw (venipuncture)?
Based on Medicare claims data, Dr. Rubin performed 913 blood draw (venipuncture) services. Research suggests that higher procedure volume is often associated with better outcomes, particularly for complex procedures. Note that Medicare data only captures patients aged 65 and older, so the total practice volume across all patients is likely higher.
Does Dr. Rubin receive payments from pharmaceutical companies?
Yes. Dr. Rubin received a total of $14,577 from 45 companies across 745 individual payments. These payments are legal, publicly disclosed under the federal Sunshine Act, and common among physicians — 57% of all U.S. physicians receive at least one industry payment. Patients may wish to ask their doctor about these relationships, especially if a recommended drug or device appears in the payment records.
How do Dr. Rubin's costs compare to other opticians in New York?
Dr. Rubin's average Medicare payment per service is $76. Note that these figures represent what Medicare pays, not your out-of-pocket cost, which depends on your specific insurance plan and deductible. Procedure-level data above shows both what was submitted and what Medicare paid for each service type.
What does Data Coverage mean?
Data Coverage (currently Very High for Dr. Rubin) measures how much public federal data is available about a provider. It is not a quality rating. A "Very High" or "High" level means the provider has data across multiple federal sources (NPPES, PECOS, Medicare Utilization, Open Payments), indicating a long track record of practice, Medicare participation, and industry disclosure. A "Low" or "Moderate" level may simply mean the provider is newer, does not see Medicare patients, or has not received any industry payments — none of which are inherently negative. Read our full methodology →
Is this data up to date?
Each data source has its own update cycle. Provider registry data (NPPES) is updated weekly. Medicare enrollment (PECOS) is updated monthly. Medicare practice data has a ~2 year lag — the most recent available is typically 2 years prior. Industry payment data (Open Payments) is published annually, usually in June, covering the prior calendar year. We display the data date prominently on each section so you always know how current it is. See our data freshness policy →
Explore related providers
Same specialty & city
Opticians in New York
Browse opticians in New York ranked by procedure volume and transparency data.
Highest volume
Top Opticians in NY
Opticians ranked by total Medicare services performed statewide.
Industry payments
Pharma Payments to Opticians in NY
Which NY opticians receive the most from drug and device companies.
By company
Salix Pharmaceuticals, a division of Bausch Health US, LLC Payments to Doctors
See all physicians who received payments from Salix Pharmaceuticals, a division of Bausch Health US, LLC.
By company
Takeda Pharmaceuticals U.S.A., Inc. Payments to Doctors
See all physicians who received payments from Takeda Pharmaceuticals U.S.A., Inc.
By company
Celgene Corporation Payments to Doctors
See all physicians who received payments from Celgene Corporation.
About this page
All data on this page is sourced verbatim from public federal records published by the U.S. Centers for Medicare & Medicaid Services (CMS): NPPES ↗, Open Payments ↗, Medicare Provider Utilization ↗, and PECOS. Publication is mandated by the Physician Payments Sunshine Act (§6002 ACA, 42 U.S.C. §1320a-7h) and the Freedom of Information Act.
This page is not medical advice, an endorsement, a recommendation, or a quality rating. Data Coverage reflects data completeness — how much federal information exists for this provider — not clinical performance, patient outcomes, or quality of care. Always verify information directly with the provider and consult a licensed clinician before making medical decisions.
Provider corrections: Provider portal · Privacy questions: Privacy Policy · Terms: Terms of Use · Methodology: Methodology